This discovery could lead to the development of new methods for CO2 separation. If this is indeed their biological function, ...

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into a technology ...

According to a new comprehensive report from The Insight Partners, the global Glaucoma Therapeutics Market is experiencing significant growth owing to ...

READING, Pennsylvania (WPVI) -- Reading Soda Works and Carbonic Supply, Inc. have been crafting small-batch soda since 1921, ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A common drug used to treat glaucoma has shown promise for neurodegenerative disease. The drug was able to prevent the ...

We are living on a planet already hotter and more unstable than at any time in human history. Pretending otherwise will only ...

A drug used to treat glaucoma may protect against tau protein buildup in the brain, a key marker of dementias such as ...

Scientists from the University of Wisconsin-Madison have reported the discovery of novel carbonic anhydrase IX (CAIX) ...

Carbonic anhydrase inhibitors show potential in reducing tau protein buildup, offering new therapeutic avenues for neurodegenerative diseases like tauopathies.

They discovered that drugs known as carbonic anhydrase inhibitors – of which the glaucoma drug methazolamide is one – clear ...